Vyome Holdings HIND
NASDAQ HIND
$1.91 -0.02 (-1.03%)
As of: Oct 1, 2026 · 3:59 PM EDT

Vyome Holdings (HIND) Non-Current Deferred Tax Liability (2020 - 2022)

Updated

Vyome Holdings (HIND) reported Non-Current Deferred Tax Liability of $367,000 for Q2 2022, down 40.3% from $615,000 a year earlier and unchanged from the prior quarter.

Analysis

Vyome Holdings (HIND) Non-Current Deferred Tax Liability (2020 - 2022) Analysis & Trends

Dating back to Q4 2020, Vyome Holdings' Non-Current Deferred Tax Liability record includes 6 quarters.

  • By year, Non-Current Deferred Tax Liability came in at $615,000 in FY2020.
  • Five-year quarterly Non-Current Deferred Tax Liability spans a low of $367,000 in Q4 2021 and a high of $615,000 in Q3 2021.
  • Per Business Quant data, the three quarters before Q2 2022 came in at $367,000 (Q1 2022), $367,000 (Q4 2021) and $615,000 (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Vyome Holdings 13.55 Mn -12.56 Mn 11,658.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 367,000.00
Mar 31, 2022 367,000.00
Dec 31, 2021 367,000.00
Sep 30, 2021 615,000.00
Jun 30, 2021 615,000.00
Dec 31, 2020 615,000.00
API Access

Vyome Holdings Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=HIND&period=max&api_key=YOUR_API_KEY